Efficacy and safety of respiratory syncytial virus prefusion F protein vaccines in adults

J Infect. 2024 Aug;89(2):106211. doi: 10.1016/j.jinf.2024.106211. Epub 2024 Jun 26.

¹ WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong Special Administrative Region of China; Laboratory of Data Discovery for Health Limited, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region of China. Electronic address: zwdu@hku.hk.
² Laboratory of Data Discovery for Health Limited, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region of China.
³ WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong Special Administrative Region of China; Laboratory of Data Discovery for Health Limited, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region of China.
⁴ Department of Genetics, University of Cambridge, Cambridge CB2 3EH, UK.
⁵ WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong Special Administrative Region of China; Institute for Health Transformation & School of Health & Social Development, Deakin University, Melbourne, Australia.

No abstract available

Publication types